RET proto-oncogene point mutations in sporadic neuroendocrine tumors

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 6, 1996, Pages 2041-2046

  Komminoth, Paul ^a   Roth, Jürgen ^a   Muletta feurer, Seraina ^a   Saremaslani, Parvin ^a   Seelentag, Walter K F ^a   Heitz, Philipp U ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOID; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MELANOMA; NEURILEMOMA; NEUROBLASTOMA; NEUROENDOCRINE TUMOR; NEUROFIBROMATOSIS; PANCREAS TUMOR; PARATHYROID ADENOMA; PHEOCHROMOCYTOMA; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTO ONCOGENE; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SIPPLE SYNDROME; THYROID MEDULLARY CARCINOMA;

ADRENAL GLAND NEOPLASMS; BASE SEQUENCE; CARCINOMA, MEDULLARY; DNA, NEOPLASM; DROSOPHILA PROTEINS; EXONS; HUMANS; MOLECULAR PROBES; MOLECULAR SEQUENCE DATA; NEUROENDOCRINE TUMORS; PHEOCHROMOCYTOMA; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; THYROID NEOPLASMS;

EID: 0029934463     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.6.2041     Document Type: Article

References (53)

1. DeLellis RA, Tischler AS. 1991 The dispersed neuroendocrine cell system. In: Kovacs K, Asa SL, eds. Functional Endocrine Pathology. Boston: Blackwell Scientific Publ.; 493-508.
2. Heitz PU, Roth J, Zuber C, Komminoth P. 1991 Markers for neural and endocrine cells in pathology. In: Gratzl M, Langley L, eds. Markers for neural and endocrine cells. Weinheim: VCH; 203-216.
3. Le Douarin NM. 1982 The neural crest. Cambridge U.K.: Cambridge University Press.
4. Le Douarin NM. 1988 On the origin of pancreatic endocrine cells. Cell. 53: 169-171.
5. Carlson KM, Dou S, Chi D, et al. 1994 Single missense mutation in the tyrosine kinase catalytic domain of the ret protooncogene is associated with multiple endocrine neoplasia type 2B. Proc Natl Acad Sci USA. 91:1579-1583.
6. Santoro M, Rosati R, Grieco M, et al. 1990 The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas. Oncogene. 5:1595-1598.
7. Matias-Guiu X, Komminoth P, Ricklan D, Wolfe HJ. 1993 Expression of the ret proto-oncogene in human medullary thyroid carcinoma: an in-situ hybridization study. Lab Invest. 68:39a. (Abstract).
8. Nakamura T, Ishizaka Y, Nagao M, Hara M, Ishikawa T. 1994 Expression of the ret proto-oncogene product in human normal and neoplastic tissues of neural crest origin. J Pathol. 172:255-260.
9. Ikeda I, Ishizaka Y, Tahira T, et al. 1990 Specific expression of the ret proto-oncogene in human neuroblastoma cell lines. Oncogene. 5:1291-1296.
10. Pachnis V, Mankoo B, Costantini F. 1993 Expression of the c-ret proto-oncogene during mouse embryogenesis. Development. 119:1005-1017.
11. Donis-Keller H, Dou S, Chi D, et al. 1993 Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet. 2:851-856.
12. Mulligan LM, Kwok JB, Healey CS, et al. 1993 Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature. 363:458-460.
13. Hofstra RMW, Landsvater RM, Ceccherini I, et al. 1994 A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature. 367:375-376.
14. De Lellis RA. 1995 Multiple endocrine neoplasia syndromes revisited. Clinical, morphologic and molecular features. Lab Invest. 72:494-505.
15. Mulligan LM, Marsh DJ, Robinson BG, et al. 1995 Genotype-phenotype correlation in MEN 2: report of the International RET mutation consortium. J Intern Med. 238:343-346.
16. Mulligan LM, Eng C, Healey CS, et al. 1994 Specific mutations of the ret proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nature Genetics. 6:70-74.
17. Komminoth P. 1995 The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas. Verh Dtsch Ges Pathol. 79:L-LV.
18. Komminoth P, Kunz EK, Hiort O, et al. 1995 Analysis of RET proto-oncogene point mutations allows for the discrimination of heritable and non-heritable medullary thyroid carcinoma. Cancer. 76:479-489.
19. Komminoth P, Kunz E, Hiort O, et al. 1994 Detection of RET proto-oncogene point mutations in paraffin-embedded pheochromocytoma specimens by nonradioactive single strand conformation polymorphism analysis and direct sequencing. Am J Pathol. 145:922-929.
20. Eng C, Smith DP, Mulligan LM, et al. 1995 A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC. Oncogene. 10:509-513.
21. Bolino A, Schuffenecker I, Luo Y, et al. 1995 RET mutations in exons 13 and 14 of FMTC patients. Oncogene. 10:2415-2419.
22. Mulligan LM, Ponder BAJ. 1995 Genetic basis of disease: multiple endocrine neoplasia type 2. J Clin Endocrinol Metab. 80:1989-1995.
23. Edery P, Lyonnet S, Mulligan L, et al. 1994 Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature. 367:378-380.
24. Eng C, Mulligan LM, Smith DP, et al. 1995 Mutation of the RET protooncogen in sporadic medullary thyroid carcinoma. Genes, Chromosomes & Cancer. 12:209-212.
25. Blaugrund JE, Johns MM, Eby YJ, et al. 1994 RET proto-oncogene mutations in inherited and sporadic medullary thyroid cancer. Hum Mol Genet. 3:1895-1897.
26. Eng C, Smith DP, Mulligan LM, et al. 1994 Point mutations within the tyrosine kinase domain of the ret proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum Mol Genet. 3:237-241.
27. Zedenius J, Wallin G, Hamberger B, Nordenskjold M, Weber G, Larsson C. 1994 Somatic and MEN 2A de now mutations identified in the RET proto-oncogene by screening of sporadic MTCs. Hum Mol Genet. 3:1259-1262.
28. Komminoth P, Muletta-Feurer S, Saremaslani P, et al. 1995 Molecular diagnosis of multiple endocrine neoplasia (MEN) in paraffin-embedded specimens. Endocr Pathol. 6:267-278.
29. Lindor NM, Honchel R, Khosla S, Thibodeau SN. 1995 Mutations in the RET protooncogene in sporadic pheochromocytomas. J Clin Endocrinol Metab. 80:627-629.
30. Beldjord C, Desclaux-Arramond F, Raffin-Sanson M, et al. 1995 The RET protooncogene in sporadic pheochromocytomas: frequent MEN 2-like mutations and new molecular defects. J Clin Endocrinol Metab. 80:2063-2068.
31. Futami H, Egawa S-I, Yamaguchi K. 1994 A novel point mutation of the ret proto-oncogene in small cell lung carcinoma cell lines. Proc Japan Acad. 70B: 210-214.
32. Sambrook J, Fritsch EF, Maniatis T. 1989 Molecular cloning. A laboratory Manual. New York: Cold Spring Harbor Laboratory Press.
33. Tautz D, Renz M. 1983 An optimized freeze-squeeze method for the recovery of DNA fragments from agarose gels. Anal Biochem. 132:14-19.
34. Ceccherini I, Hofstra RMW, Luo Y, et al. 1994 DNA polymorphisms and conditions for SSCP analysis of the 20 exons of the ret proto-oncogene. Oncogene. 9:3025-3029.
35. Cote GJ, Khorana S, Schultz PN, Gagel RF. Differential amplification of RET proto-oncogene exon 11 alleles: a potential source of misdiagnosis. Fifth International Workshop on Multiple Endocrine Neoplasia, Stockholm Archipelago, Sweden, 1994, 618:74 (Abstract).
36. Avantaggiato V, Dathan NA, Grieco M, et al. 1994 Developmental expression of the ret protooncogene. Cell Growth & Differ. 5:305-311.
37. Tsuzuki T, Takahashi M, Asai N, Iwashita T, Matsuyama M, Asai J. 1995 Spatial and temporal expression of the ret proto-oncogene product in embryonic, infant and adult rat tissues. Oncogene. 10:191-198.
38. Nagao M, Ishizaka Y, Nakagawara A, et al. 1990 Expression of ret proto-oncogene in human neuroblastomas. Jpn J Cancer Res. 81:309-312.
39. Takahashi M, Buma Y, Taniguchi M. 1991 Identification of the ret proto-oncogene products in neuroblastoma and leukemia cells. Oncogene. 6:297-301.
40. Padberg BC, Schröder S, Jochum W, et al. 1995 Absence of RET proto-oncogene mutations in sporadic hyperplastic and neoplastic lesions of the parathyroid gland. Am J Pathol. 147:1600-1607.
41. Anderson RJ, Lufkin EG, Sizemore GW, Carney JA, Sheps SG, Silliman YE. 1981 Acromegaly and pituitary adenoma with pheochromocytoma: a variant of multiple endocrine neoplasia. Clin Endocrinol. 14:605-612.
42. Santoro M, Carlomagno F, Romano A, et al. 1995 Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science. 267:381-383.
43. Spada A, Vallar L. 1992 G-protein oncogenes in acromegaly. Horm Res. 38: 90-93.
44. Yoshimoto K, Iwahana H, Fukuda A, Sano T, Itakura M. 1993 Rare mutations of the Gs alpha subunit gene in human endocrine tumors. Mutation detection by polymerase chain reaction-primer-introduced restriction analysis. Cancer. 72:1386-1393.
45. Yoshimoto K, Iwahana H, Fukuda A, et al. 1992 ras mutations in endocrine tumors: mutation detection by polymerase chain reaction-single strand conformation polymorphism. Jpn J Cancer Res. 83:1057-1062.
46. Pei L, Melmed S, Scheithauer B, Kovacs K, Prager D. 1994 H-ras mutations in human pituitary carcinoma metastases. J Clin Endocrinol Metab. 78:842-846.
47. Yoshimoto K, Iwahana H, Fukuda A, Sano T, Saito S, Itakura M. 1992 Role of p53 mutations in endocrine tumorigenesis: mutation detection by polymerase chain reaction-single strand conformation polymorphism. Cancer Res. 52:5061-5064.
48. Yana I, Nakamura T, Shin E, et al. 1992 Inactivation of the p53 gene is not required for tumorigenesis of medullary thyroid carcinoma or pheochromocytoma. Jpn J Cancer Res. 83:1113-1116.
49. Sameshima Y, Matsuno Y, Hirohashi S, et al. 1992 Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small-cell lung carcinoma. Oncogene. 7:451-457.
50. Lin SR, Lee YJ, Tsai JH. 1994 Mutations of the p53 gene in human functional adrenal neoplasms. J Clin Endocrinol Metab. 78:483-491.
51. Mulligan LM, Gardner E, Smith BA, Mathew CG, Ponder BA. 1993 Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2. Genes Chromosomes Cancer. 6:166-177.
52. Takayama H, Suzuki T, Mugishima H, et al. 1992 Deletion mapping of chromosomes 14q and 1p in human neuroblastoma. Oncogene. 7:1185-1189.
53. Bale AE. 1994 Molecular mechanisms of neoplasia in MEN type 1-related and sporadic tumors of the pancreatic islet cells. Endocrinol Metabol Clin North Am. 23:109-115.